Vidyya Medical News Servicesm
Vidyya, from the Sanskrit "vaidya," a practitioner who has come to understand the science of life.

Volume 1 Published - 14:00 UTC    08:00 EST    23-May-2000      
Issue 40 Next Update - 14:00 UTC 08:00 EST    24-May-2000      

Vidyya Home  Vidyya

Home Of Our Sponsor, Vidyya.  Vidyya. Home

Vidyya Archives  Vidyya Archives

Search Vidyya  Search Vidyya

Visit Our Library  Ex Libris

Subscribe To Our News Service  Subscriptions

All About Us  About Vidyya



















Proceed To Article Chemotherapy With Bone Marrow Transplant For Breast Cancer Deserves Consideration
In an open letter, NCI Director Richard Klausner, MD, urged physicians not to dismiss bone-marrow-transplant clinical trials as an option for their breast cancer patients. Although preliminary results from some transplant trials have been disappointing, they should not be generalized to all patients and, contrary to some widespread reports, the questions regarding transplantation and breast cancer have not been resolved. More...

Proceed To Article High-Dose Chemotherapy Trials With Progenitor Cell Support In Breast Cancer
Practitioners interested in learning more about the NCI's call to physicians to encourage patient participation in ongoing high-dose chemotherapy clinical trials are invited to examine the information Vidyya has compiled. The trials listed include a trial for which the NCI is actively seeking volunteers, plus additional chemotherapy trials that have a bone marrow transplant element. More....

Proceed To Article Will High-Dose Chemotherapy For Breast Cancer Continue?
More than 15,000 breast cancer patients have been treated with a largely unproven procedure - high doses of chemotherapy followed by blood cell transplants to replace bone marrow damaged by the chemotherapy. After a few encouraging preliminary reports, breast cancer patients began demanding the treatment. However, news on the treatments isn't good. Two recently published studies found that high doses of chemotherapy are no more effective than standard chemotherapy. Results from a third study, positive for high-dose treatment, has been discounted for serious fraud. In the meantime, officials at the NCI are left looking for trial participants. Read Will High-Dose Chemotherapy Continue?
Proceed To Article Lower Your Cholesterol, Lose Your Mind
Two new studies published in the May issue of The American Journal of Medicine show that cholesterol lowering results in minor impairments in one or more aspects of cognitive function. In trials studying the cognitive function of patients taking lovastatin, a popular cholesterol lowering medication, some small but negative effects on cognitive function were discovered. Read Lower Your Cholesterol, Lose Your Mind.

Vidyya. Home |  Ex Libris |  Vidyya  | 
Subscription Information |  About Vidyya |  Vidyya Archives | 

Editor: Susan K. Boyer, RN
© Vidyya. All rights reserved.